Trial · NCT06296836
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean glucose levels | During hospitalization | Average of daily glucose levels during hospitalization |
| Secondary | Incidence of hyperglycemia greater than 300 mg/dl. | During hospitalization | Glucose \> 300 |
| Secondary | Incidence of hypoglycemia (Glu = 54 - 70). | During hospitalization | Glu = 54 - 70 |
| Secondary | Incidence of moderate hypoglycemia (Glu < 54) | During hospitalization | Glu \< 54 |
| Secondary | Incidence of severe hypoglycemia (Glu < 54 with symptoms) | During hospitalization | Glu \< 54 with symptoms |
| Secondary | Mean lactic acid levels. | During hospitalization | Mean lactic acid levels |
| Secondary | Incidence of lactic acid levels greater than 2.0. | During hospitalization | Lactic acid \> 2.0 |
| Secondary | Mean anion gap. | During hospitalization | Mean anion gap, a calculated value |
| Secondary | Incidence of anion gap > 11 | During hospitalization | Anion Gap \> 11 |
| Secondary | Incidence of elevated lactic acid level or anion gap. | During hospitalization | Lactic acid \> 2.0 or Anion Gap \> 11 |
| Secondary | Incidence of inadvertently not continuing metformin on discharge | At discharge | Transitions of care |
| Secondary | GI adverse effects | Within 3 days of discharge | GI side effects after discharge |
| Secondary | Mortality | 30 +/- 3 days after discharge | Mortality as determined via chart search and follow up phone call |
| Other | Mean glucose levels while receiving metformin in the continuation arm and while not receiving metformin in the discontinuation arm | During hospitalization | Mean daily glucose levels will only be included for the days in which the subjects received or did not receive metformin as per their assigned arm. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06296836/registered